2014
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/978-1-62703-610-8_11
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/isbn/9781627036108
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_156FC9B26D1E7
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
A. Delzor et al., « Lentiviral vectors in Huntington's disease research and therapy », Serveur académique Lausannois, ID : 10.1007/978-1-62703-610-8_11
We describe here the potential of viral-mediated gene transfer for the modeling and treatment of Huntington's disease, focusing in particular on strategies for the tissue-specific targeting of various CNS cells. The protocols described here cover the design of lentiviral vectors, strategies for modifying their tropism, including the use of various envelopes and tissue-specific promoters, and the potential of miRNA to regulate transgene expression.